About this trial
The aim of the study is to investigate the relationship between central sensitization parameters and cognitive dysfunction in patients with fibromyalgia.The main questions it aims to answer are:
Do central sensitization symptoms affect cognitive dysfunction in patients with fibromyalgia? To what extent do central sensitization symptoms affect objective and subjective cognitive complaints in fibromyalgia patients? How do cognitive complaints relate to other clinical parameters, including disease severity, in these patients?
Eligibility criteria
Qualifiers
Being diagnosed with fibromyalgia according to American College of Rheumatology 2016 criteria
Being between 18-65 years old
Being literate
Accepting to participate in the study
Disqualifiers
Concomitant systemic inflammatory disease, central nervous system disease (cortical involvement), active infection and malignancy history
History of illness that may lead to cognitive impairment
Being <18 and >65 years old
Being illiterate
Trial design
Treatments tested in this trial
- Central Sensitization Inventory
- The Montreal Cognitive Assessment
- Cognitive Symptom Severity Scale-Extended
- Fibromyalgia Impact Questionnaire
- Numeric rating scale
- Hospital Anxiety and Depression Scale